Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

...

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Solution	355,798 L.L
R03BB04	TIOVA-T	G	Tiotropium bromide monohydrate - 18mcg	18mcg	Rotacaps	384,339 L.L
D06AA04	TETRACYCLINE OINTMENT	G	Tetracycline HCl - 3%	3%	Ointment	107,507 L.L
D06AX	TRIPLE ANTIBIOTIC ORIGINAL OINTMENT	G	Bacitracin - 400U, Neomycin (sulfate) - 3.5mg, Polymyxin B (sulfate) - 5000U		Ointment	560,382 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
D11AH01	TACRUS	G	Tacrolimus monohydrate - 0.1%	0.1%	Ointment	1,857,190 L.L
D11AX	TRIO-2000	G	Hydroquinone - 4%, Tretinoin - 0.05%, Hydrocortisone acetate - 1%		Ointment	2,495,068 L.L
R02A	TRACHISAN	G	Lidocaine HCl - 1mg, Tyrothricin - 0.5mg, Chlorhexidine gluconate - 1mg		Lozenge	228,453 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	35,536,214 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	42,155,107 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,749,778 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	73,949,465 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	5,813,990 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	691,446 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	832,420 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	1,212,951 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml		Injectable suspension	4,020,777 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	1,395,532 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	191,162,296 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	191,162,296 L.L
A10BJ05	TRULICITY	BioTech	Dulaglutide - 0.75mg/0.5ml	0.75mg/0.5ml	Injectable solution	10,165,201 L.L
A10BJ05	TRULICITY	BioTech	Dulaglutide - 1.5mg/0.5ml	1.5mg/0.5ml	Injectable solution	10,165,201 L.L
A10BJ05	TRULICITY	BioTech	Dulaglutide - 3mg/0.5ml	3mg/0.5ml	Injectable solution	10,165,201 L.L
A10BJ05	TRULICITY	BioTech	Dulaglutide - 4.5mg	4.5mg/0.5ml	Injectable solution	10,165,201 L.L
C02CA06	TACHYBEN	G	Urapidil - 25mg/5ml	25mg/5ml	Injectable solution	1,439,283 L.L
M01AB05	TRATUL	G	Diclofenac Deanol - 90mg	90mg	Injectable solution	490,503 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L

...